Imagyn Eyes Australia
Dow Jones
NEWPORT BEACH —
Imagyn Medical Technologies Inc. said it has received clearance to begin marketing its SiteSelect breast biopsy system in Australia. The company said it will start shipping the product in January and plans to launch the product in the U.S. early next year.
SiteSelect allows sampling of a breast mass without open surgery.
